Major gaps in the information provided to patients before implantation of cardioverter defibrillators: a prospective patient European evaluation
EP Europace · 2023
DOI: 10.1093/europace/euac275 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift EP Europace, 2023. Verfasst von Łukasz Januszkiewicz und 8 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland. Hauptthemen laut MEDLINE: Quality of Life, Defibrillators, Implantable. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aims
Information provided to patients prior to implantable cardioverter-defibrillator (ICD) insertion and their participation in the decision-making process are crucial for understanding ICD function and accepting this lifelong therapy. The aim of this study is to evaluate the extent to which different aspects related to ICD and quality of life were transmitted to patients prior to ICD implantation. Methods and results Prospective, multicenter European study with an online questionnaire initiated by the European Heart Rhythm Association. The questionnaire was filled-in directly and personally by the ICD patients who were invited to participate. A total of 1809 patients (majority in their 40s–70s, with 624 women, 34.5%) from 10 European countries participated in the study. The median time from first ICD implantation was 5 years (interquartile range 2–10). Overall, 1155 patients (71.5%) felt optimally informed at the time of device implantation, however many respondents received no information about ICD-related complications (n = 801, 49.6%), driving restrictions (n = 718, 44.5%), and possibility of end-of-life ICD deactivation (n = 408, 25.4%). Of note, women were less frequently involved in the decision-making process than men (47.3% vs. 55.9%, P = 0.003) and reported to be less often optimally informed before ICD implantation than men (61.2% vs. 76.8%, P < 0.001). More women mentioned the desire to have learned more about ICD therapy and the benefit/risk balance (45.4% vs. 33.7% of men; P < 0.001).
Conclusions
This patient-based evaluation provides alarming findings on the lack of information provided to patients prior ICD implantation, particularly for women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
- Cardiology Department, Hospital da Luz Arrabida, V. N. Gaia, Portugal.
- University of Paris, Paris, France.
- Cardiology Department, European Georges Pompidou Hospital, Paris, France.
- Paris Cardiovascular Research Center, INSERM Unit 970, 56 Rue Leblanc, 75015, Paris, France.
- Barts Heart Centre, St. Bartholomew's Hospital, London, UK.
ORCID-Profile: Łukasz Januszkiewicz, Sérgio Barra, Eloi Marijon, Rui Providencia, Carlo de Asmundis, Julian K R Chun, Michał M Farkowski, Giulio Conte, Serge Boveda
Zitieren
APA
Januszkiewicz, Ł., Barra, S., Marijon, E., Providencia, R., de Asmundis, C., Chun, J. K. R., Farkowski, M. M., Conte, G., & Boveda, S. (2023). Major gaps in the information provided to patients before implantation of cardioverter defibrillators: a prospective patient European evaluation. EP Europace. https://doi.org/10.1093/europace/euac275
Vancouver
Januszkiewicz Ł, Barra S, Marijon E, Providencia R, de Asmundis C, Chun JKR, et al. Major gaps in the information provided to patients before implantation of cardioverter defibrillators: a prospective patient European evaluation. EP Europace. 2023. doi:10.1093/europace/euac275
BibTeX
@article{Januszkiewicz2023,
author = {Januszkiewicz, Łukasz and Barra, Sérgio and Marijon, Eloi and Providencia, Rui and de Asmundis, Carlo and Chun, Julian K R and Farkowski, Michał M and Conte, Giulio and Boveda, Serge},
title = {Major gaps in the information provided to patients before implantation of cardioverter defibrillators: a prospective patient European evaluation},
journal = {EP Europace},
year = {2023},
doi = {10.1093/europace/euac275}
}
EUVIMED